Physician profile
Michael M Dao
NPI 1437321932
$55,614.16
in general payments reported to CMS, 2019-2025
100 companies · $11K in 2025
The $11K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $7,527 · 2021: $6,862 · 2022: $6,264 · 2023: $6,441 · 2024: $7,580 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21K · Consulting Fee: $3,050 · Education: $180 · Travel and Lodging: $4.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21,295.21 |
| Consulting Fee | $3,050.00 |
| Education | $180.02 |
| Travel and Lodging | $4.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $9,280.50 | 2019-2025 | Vraylar, Linzess, Viberzi |
| Astrazeneca Pharmaceuticals LP | $5,029.07 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $4,229.68 | 2019-2025 | Otezla, Evenity, Repatha |
| Agios Pharmaceuticals, INC. | $3,250.71 | 2024-2025 | Pyrukynd |
| Novo Nordisk INC | $3,250.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Gilead Sciences, INC. | $2,806.64 | 2019-2025 | Vemlidy, Livdelzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,581.21 | 2019-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $1,305.50 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $1,267.58 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,169.98 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,129.28 | 2019-2025 | Trulance, Xifaxan, Relistor |
| Amarin Pharma, INC. | $1,035.97 | 2019-2022 | |
| Pfizer INC. | $920.11 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $854.70 | 2024-2025 | Voquezna |
| Nestle Healthcare Nutrition INC. | $829.63 | 2020-2023 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $764.55 | 2019-2022 | |
| Glaxosmithkline, LLC. | $737.23 | 2019-2025 | Arexvy, Nucala, Shingrix |
| Janssen Pharmaceuticals, INC | $700.22 | 2020-2024 | Xarelto, Spravato |
| Aimmune Therapeutics, INC. | $689.57 | 2024-2025 | Zenpep |
| Neurocrine Biosciences, INC. | $661.73 | 2023-2025 | Ingrezza, Ongentys |
| Horizon Therapeutics Plc | $660.49 | 2019-2023 | Krystexxa |
| Almatica Pharma LLC | $654.54 | 2022-2024 | Loreev Xr, Gralise, Sertraline Hcl |
| Ardelyx, INC. | $555.74 | 2024-2025 | Ibsrela |
| Allergan, INC. | $539.74 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $539.64 | 2019-2023 | |
| Astellas Pharma US INC | $478.95 | 2019-2024 | Veozah, Myrbetriq |
| Kowa Pharmaceuticals America, INC. | $456.78 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Sun Pharmaceutical Industries INC. | $450.83 | 2020-2023 | Cequa |
| Merck Sharp & Dohme LLC | $447.52 | 2019-2025 | Gardasil 9, Verquvo, Belsomra |
| Mylan Specialty L.P. | $443.66 | 2021-2024 | Yupelri |
| Merz North America, INC. | $431.71 | 2019-2020 | |
| Axsome Therapeutics, INC. | $420.12 | 2023-2025 | Auvelity, Symbravo |
| Ironwood Pharmaceuticals, INC | $382.05 | 2021-2025 | Linzess |
| Genzyme Corporation | $353.18 | 2019-2024 | |
| Madrigal Pharmaceuticals | $340.51 | 2024-2025 | Rezdiffra, Resmetirom |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $312.88 | 2022-2025 | Caplyta |
| Ucb, INC. | $280.14 | 2022-2024 | Cimzia, Briviact |
| Viatris Specialty LLC | $266.04 | 2025 | Yupelri |
| Vivus LLC | $261.15 | 2021-2025 | Qsymia |
| Ibsa Pharma INC. | $237.74 | 2020-2025 | Licart, Tirosint, Tirosint |
| Antares Pharma, INC. | $202.60 | 2020-2023 | Nocdurna, Xyosted, Tlando |
| Eisai INC. | $202.04 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $201.85 | 2022-2025 | Nuzyra, Xhance |
| Optinose US, INC. | $201.12 | 2019-2025 | |
| Adamas Pharmaceuticals, INC. | $188.55 | 2020 | |
| Esperion Therapeutics, INC. | $181.34 | 2022 | |
| Dexcom, INC. | $179.43 | 2020-2025 | Dexcom G6 Transmitter |
| Scilex Pharmaceuticals INC. | $179.22 | 2019-2024 | |
| Biogen, INC. | $172.26 | 2020-2025 | Leqembi |
| Regeneron Healthcare Solutions, INC. | $167.76 | 2019-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $163.63 | 2019-2021 | |
| Edwards Lifesciences Corporation | $160.74 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Radius Health, INC. | $151.98 | 2020-2025 | Tymlos |
| Cequr Corporation | $144.31 | 2022-2025 | Cequr Simplicity |
| Genentech USA, INC. | $137.93 | 2019-2021 | |
| Dynavax Technologies Corporation | $137.23 | 2019-2022 | |
| Corcept Therapeutics | $136.71 | 2024-2025 | Korlym |
| Lundbeck LLC | $135.36 | 2023-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $133.33 | 2024-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $125.08 | 2022 | |
| Vanda Pharmaceuticals INC. | $125.00 | 2024 | Fanapt |
| Mayne Pharma Commercial LLC | $121.37 | 2025 | |
| Tolmar, INC. | $115.21 | 2023-2025 | Jatenzo |
| Impel Pharmaceuticals INC. | $114.99 | 2022 | |
| Mannkind Corporation | $110.22 | 2020-2025 | |
| Verona Pharma, INC. | $107.15 | 2025 | Ohtuvayre |
| Celgene Corporation | $105.26 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $102.00 | 2024-2025 | Rexulti |
| Intuitive Surgical, INC. | $86.75 | 2022 | |
| Abbott Laboratories | $80.63 | 2024-2025 | Freestyle Libre 3 |
| Janssen Biotech, INC. | $71.02 | 2025 | Tremfya |
| Redhill Biopharma INC. | $70.98 | 2020-2023 | Talicia |
| Boston Scientific Corporation | $69.26 | 2022 | |
| Dermira, INC. | $57.49 | 2019 | |
| Arcutis Biotherapeutics, INC. | $57.47 | 2023-2024 | Zoryve |
| Insulet Corporation | $56.81 | 2020-2025 | Omnipod |
| Neuronetics, INC. | $54.65 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $50.18 | 2021 | |
| Oyster Point Pharma, INC. | $48.36 | 2022-2024 | Tyrvaya |
| Halozyme INC | $47.56 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $45.81 | 2025 | Austedo Xr |
| Corium, LLC | $42.91 | 2022-2023 | Adlarity |
| Ascend Therapeutics US, LLC | $41.20 | 2020-2021 | |
| Medtronic, INC. | $38.17 | 2021-2025 | Venaseal |
| Depuy Synthes Sales INC. | $37.35 | 2023 | Orthovisc, Monovisc |
| Organon LLC | $30.22 | 2025 | Vtama |
| Baxter Healthcare | $24.93 | 2024 | Hillrom - Monarch Airway Clearance System |
| Aerin Medical INC. | $24.50 | 2025 | |
| Averitas Pharma INC. | $23.97 | 2025 | Qutenza |
| Mdd US Operations, LLC | $23.82 | 2023 | Apokyn |
| Leo Pharma INC. | $22.53 | 2022 | |
| Valinor Pharma, LLC | $21.54 | 2023 | Movantik |
| Avanir Pharmaceuticals, INC. | $21.20 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $19.80 | 2022 | |
| Pulmonx Corporation | $19.27 | 2020 | |
| Nevro Corp. | $19.23 | 2021 | |
| Phadia US INC. | $19.17 | 2019 | |
| Integra Lifesciences Corporation | $18.99 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Ani Pharmaceuticals, INC. | $18.79 | 2025 | Purified Cortrophin Gel |
| Verity Pharmaceuticals INC. | $18.74 | 2025 | Tlando |
Drugs and devices associated with these payments
Pyrukynd $3,251Farxiga $1,228Breztri $1,017Zenpep $927Voquezna $855Otezla $796Linzess $729Jardiance $727Airsupra $717Creon $715Kerendia $689Ingrezza $662Leqvio $656Loreev Xr $609Evenity $585Repatha $576Ibsrela $556Yupelri $504Vemlidy $452Tepezza $435Ubrelvy $396Trulance $389Vraylar $366Mounjaro $347Arexvy $288Auvelity $279Dupixent $253Rexulti $237Nurtec Odt $234Zoryve $230Caplyta $223Nucala $202Rezdiffra $194Qsymia $188Prolia $187Nuzyra $186Tlando $183Licart $180Leqembi $174Ozempic $169Shingrix $165Xyosted $165Veozah $161Edwards Sapien 3 Transcatheter Heart Valve (Thv) $161Ztlido $160Qulipta $153Xarelto $148Resmetirom $146Xifaxan $144Symbravo $142Dexcom G6 Transmitter $139Korlym $137Gemtesa $133Fanapt $125Xiidra $124Bijuva $121Entresto $120Cequr Simplicity $119Livdelzi $118Nocdurna $117Krystexxa $117Viberzi $116Jatenzo $115Zavzpret $113Tirosint $111Zepbound $109Ohtuvayre $107Paxlovid $104Trulicity $103Eliquis $99.37Trelegy Ellipta $95.97Cimzia $95.04Rybelsus $94.88Gralise $94.60Afrezza $88.23Gardasil 9 $83.01Freestyle Libre 3 $80.63Verquvo $79.93Xhance $79.92Tymlos $78.91Livalo $76.64Seglentis $76.64Belsomra $74.19Emgality $73.04Tremfya $71.02Cequa $70.14Capvaxive $58.40Botox $55.19Kisunla $49.35Ongentys $47.17Austedo Xr $45.81Omnipod $45.59Synjardy $41.52Spravato $40.58Relistor $38.97Gardasil $37.29Rhapsido $36.28Briviact $31.40Vtama $30.22Tyrvaya $27.18
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.